دورية أكاديمية

The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study

التفاصيل البيبلوغرافية
العنوان: The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study
المؤلفون: Lago, Tiffany R.Aff1, Aff2, Aff3, Brownstein, Michael J., Page, Emily, Beydler, Emily, Manbeck, Adrienne, Beale, Alexis, Roberts, Camille, Balderston, NicholasAff1, Aff5, Damiano, Eve, Pineles, Suzanne L.Aff3, Aff6, Simon, NealAff4, Aff7, Ernst, Monique, Grillon, Christian
المصدر: Psychopharmacology. 238(9):2393-2403
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:00333158
14322072
DOI:10.1007/s00213-021-05861-4